Hyperactivated HLA-DR+ T cells have been shown to down-modulate cell surface expression of the co-stimulatory molecules CD27 and CD28 (28–31), which are otherwise decisively involved in the regulation of T cell activation (32, 33), the formation and maintenance of antigen-experienced T cells (34) and tumor immune surveillance (35). This evidence concerns the gene CD28 and neoplasm.